Maarten J IJzerman (M J IJzerman, Maarten IJzerman)

Scopus Author ID Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 23

Top Venues

Expert review of pharmacoeconomics & outcomes research

PharmacoEconomics

Journal of medical Internet research

Cost effectiveness and resource allocation : C/E

University of Melbourne

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Melbourne May 1o 2018

Australia

Chair :: Centre for Cancer Research and Centre for Health Policy

Publications

Mussab Fagery, Hadi A Khorshidi, Stephen Q Wong, Martin Vu, Maarten J IJzerman
Health Economic Evidence and Modeling Challenges for Liquid Biopsy Assays in Cancer Management: A Systematic Literature Review. PharmacoEconomics (2023)
Piers Gillett, Robert K Mahar, Nancy R Tran, Mark Rosenthal, Maarten J IJzerman
Developing and validating a multi-criteria decision analytic tool to assess the value of cancer clinical trials: evaluating cancer clinical trial value. Cost effectiveness and resource allocation : C/E 21 (1) (2023)
Martin Vu, Koen Degeling, Ella R Thompson, Piers A Blombery, David Westerman, Maarten J IJzerman
Cost Effectiveness of Molecular Diagnostic Testing Algorithms for the Treatment Selection of Frontline Ibrutinib for Patients with Chronic Lymphocytic Leukemia in Australia. Applied health economics and health policy (2023)
Martin Vu, Koen Degeling, Ella R Thompson, Piers A Blombery, David Westerman, Maarten J IJzerman
Health economic evidence for the use of molecular biomarker tests in hematological malignancies: A systematic review. European journal of haematology 108 (6) (2022)
Carina M Behr, Hendrik Koffijberg, Koen Degeling, Rozemarijn Vliegenthart, Maarten J IJzerman
Can we increase efficiency of CT lung cancer screening by combining with CVD and COPD screening? Results of an early economic evaluation. European radiology 32 (5) (2022)
Kendrick Koo, Nathan Papa, Melanie Evans, Michael Jefford, Maarten J IJzerman, Victoria M White, Sue M Evans, Eli Ristevski, Jon Emery, Jeremy Millar
Mapping disadvantage: identifying inequities in functional outcomes for prostate cancer survivors based on geography. BMC cancer 22 (1) (2022)
Michelle M A Kip, Sytze de Roock, Gillian Currie, Deborah A Marshall, Luiza R Grazziotin, Marinka Twilt, Rae S M Yeung, Susanne M Benseler, Sebastiaan J Vastert, Nico Wulffraat, Joost F Swart, Maarten J IJzerman
Pharmacological treatment patterns in patients with juvenile idiopathic arthritis in the Netherlands: a real-world data analysis. Rheumatology (Oxford, England) (2022)
Aarushi Gupta, Joseph Antony Cafazzo, Maarten J IJzerman, Joost F Swart, Sebastiaan J Vastert, Nicolaas M Wulffraat, Susanne M Benseler, Deborah A Marshall, Rae S M Yeung, Marinka Twilt
Genomic Health Literacy Interventions in Pediatrics: Scoping Review. Journal of medical Internet research 23 (12) (2021)
Deon Lingervelder, Hendrik Koffijberg, Jon D Emery, Paul Fennessy, Christopher P Price, Harm van Marwijk, Torunn B Eide, Sverre Sandberg, Jochen W L Cals, Joke T M Derksen, Ron Kusters, Maarten J IJzerman
How to Realize the Benefits of Point-of-Care Testing at the General Practice: A Comparison of Four High-Income Countries. International journal of health policy and management (2021)
Koen Degeling, Martin Vu, Hendrik Koffijberg, Hui Li Wong, Miriam Koopman, Peter Gibbs, Maarten J IJzerman
Health Economic Models for Metastatic Colorectal Cancer: A Methodological Review. PharmacoEconomics 38 (7) (2021)
Koen Degeling, Hui Li Wong, Hendrik Koffijberg, Azim Jalali, Jeremy Shapiro, Suzanne Kosmider, Rachel Wong, Belinda Lee, Matthew Burge, Jeanne Tie, Desmond Yip, Louise Nott, Adnan Khattak, Stephanie Hui-Su Lim, Susan Caird, Peter Gibbs, Maarten J IJzerman
Simulating Progression-Free and Overall Survival for First-Line Doublet Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer Patients Based on Real-World Registry Data. PharmacoEconomics 38 (11) (2021)
Robert K Mahar, Myra B McGuiness, Bibhas Chakraborty, John B Carlin, Maarten J IJzerman, Julie Anne Simpson
A scoping review of studies using observational data to optimise dynamic treatment regimens. BMC medical research methodology 21 (1) (2021)
Sallie-Anne Pearson, Nicole Pratt, Juliana de Oliveira Costa, Helga Zoega, Tracey-Lea Laba, Christopher Etherton Beer, Frank M Sanfilippo, Alice Morgan, Lisa Kalisch Ellett, Claudia Bruno, Erin A Kelty, Maarten J IJzerman, David B Preen, Claire M Vajdic, David A Henry
Generating Real-World Evidence on the Quality Use, Benefits and Safety of Medicines in Australia: History, Challenges and a Roadmap for the Future. International journal of environmental research and public health 18 (24) (2021)
Koen Degeling, Nancy N Baxter, Jon David Emery, Mark E Jenkins, Fanny Franchini, Peter Gibbs, Gregory B Mann, Grant A McArthur, Benjamin J Solomon, Maarten J IJzerman
An inverse stage-shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID-19 pandemic. Asia-Pacific journal of clinical oncology 17 (4) (2021)
Maarten J IJzerman, Jasper de Boer, Arun Azad, Koen Degeling, Joel Geoghegan, Chelsee Hewitt, Frédéric Hollande, Belinda Lee, Yat Ho To, Richard W Tothill, Gavin Wright, Jeanne Tie, Sarah-Jane Dawson
Towards Routine Implementation of Liquid Biopsies in Cancer Management: It Is Always Too Early, until Suddenly It Is Too Late. Diagnostics (Basel, Switzerland) 11 (1) (2021)
Frederik van Delft, Mirte Muller, Rom Langerak, Hendrik Koffijberg, Valesca Retèl, Daan van den Broek, Maarten J IJzerman
Modeling Diagnostic Strategies to Manage Toxic Adverse Events following Cancer Immunotherapy. Medical decision making : an international journal of the Society for Medical Decision Making 41 (6) (2021)
Frederik van Delft, Hendrik Koffijberg, Valesca Retèl, Michel van den Heuvel, Maarten J IJzerman
The Validity and Predictive Value of Blood-Based Biomarkers in Prediction of Response in the Treatment of Metastatic Non-Small Cell Lung Cancer: A Systematic Review. Cancers 12 (5) (2020)
Michelle M A Kip, Sytze de Roock, Gillian R Currie, Deborah A Marshall, Luiza Raquel Grazziotin, Marinka Twilt, Rae S M Yeung, Susanne M Benseler, Maud A Schreijer, Sebastiaan J Vastert, Nicolaas M Wulffraat, Annet van Royen-Kerkhof, Joost F Swart, Maarten J IJzerman
Costs of medication use among patients with juvenile idiopathic arthritis in the Dutch healthcare system. Expert review of pharmacoeconomics & outcomes research 21 (5) (2020)
A M Sofie Berghuis, Carolien H M van Deurzen, Hendrik Koffijberg, Leon W M M Terstappen, Stefan Sleijfer, Maarten J IJzerman
Real-world data on discordance between estrogen, progesterone, and HER2 receptor expression on diagnostic tumor biopsy versus tumor resection material. Breast cancer research and treatment 175 (2) (2019)
Maarten J IJzerman, A M Sofie Berghuis, Johann S de Bono, Leon W M M Terstappen
Health economic impact of liquid biopsies in cancer management. Expert review of pharmacoeconomics & outcomes research 18 (6) (2018)
Koen Degeling, Maarten J IJzerman, H Koffijberg
A scoping review of metamodeling applications and opportunities for advanced health economic analyses. Expert review of pharmacoeconomics & outcomes research 19 (2) (2018)
Annemieke Witteveen, Jan W M Otten, Ingrid M H Vliegen, Sabine Siesling, Judith B Timmer, Maarten J IJzerman
Risk-based breast cancer follow-up stratified by age. Cancer medicine 7 (10) (2018)
Karlijn Cranen, Catharina G M Groothuis-Oudshoorn, Miriam M R Vollenbroek-Hutten, Maarten J IJzerman
Toward Patient-Centered Telerehabilitation Design: Understanding Chronic Pain Patients' Preferences for Web-Based Exercise Telerehabilitation Using a Discrete Choice Experiment. Journal of medical Internet research 19 (1) (2017)

Maarten J IJzerman.css-eqlu8i{font-size:small;padding-left:4px;} (M J IJzerman, Maarten IJzerman)

Publication Activity (10 Years)

Top Topics

Top Venues

Maarten J IJzerman (M J IJzerman, Maarten IJzerman)